| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 150, Issue 12 5596-5603, Copyright © 1993 by American Association of Immunologists
ARTICLES |
CD Richards, M Shoyab, TJ Brown and J Gauldie
Department of Pathology, McMaster University, Hamilton, Ontario, Canada.
Tissue inhibitor of metalloproteinases (TIMP-1) is a potent inhibitor of activated matrix metalloproteinases (MMP) such as collagenase, stromelysin, and gelatinase, and thus helps to control extracellular matrix metabolism and deposition by connective tissue cells. Since various cytokines and growth factors can modify the production of MMP and TIMP-1, we explored the action of oncostatin M (OM), a unique lymphocyte- and monocyte-derived cytokine, on expression of these proteins. We examined the regulation of TIMP-1 expression in cultured human fibroblasts by cytokines including OM, IL-6, leukemia inhibitory factor (LIF), and IL-1 alpha. When used at levels of 5 to 50 ng/ml, OM, IL-6, LIF, and IL-1 alpha elevated the TIMP-1 expression at the RNA level in fibroblasts of lung or synovial origin. Interestingly, OM stimulation resulted in highest levels of TIMP-1 RNA and protein synthesis. However, unlike IL-1 alpha, the cytokines OM, IL-6, and LIF did not induce MMP or PGE2 release. OM also enhanced TIMP-1 mRNA levels in the H2981 lung carcinoma and HepG2 hepatoma cell lines. The results suggest that OM as well as IL-6 and LIF, other cytokines acting through similar receptor pathways, may act to inhibit net MMP activity by specifically up-regulating TIMP-1 expression. The selective induction of TIMP-1 by OM may be influential in altering matrix destruction in chronic inflammation and tumor metastasis.
This article has been cited by other articles:
|
|
 |
|
  A. H. Harrill, P. K. Ross, D. M. Gatti, D. W. Threadgill, and I. Rusyn Population-Based Discovery of Toxicogenomics Biomarkers for Hepatotoxicity Using a Laboratory Strain Diversity Panel Toxicol. Sci., July 1, 2009; 110(1): 235 - 243. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Tomita, A. Yamada, M. Miyakoshi, T. Kido, F. Sheikh, A. Srisodsai, A. Miyajima, R. P. Donnelly, and S. Kimura Oncostatin M Regulates Secretoglobin 3A1 and 3A2 Expression in a Bidirectional Manner Am. J. Respir. Cell Mol. Biol., May 1, 2009; 40(5): 620 - 630. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Hintzen, C. Evers, B. E. Lippok, R. Volkmer, P. C. Heinrich, S. Radtke, and H. M. Hermanns Box 2 Region of the Oncostatin M Receptor Determines Specificity for Recruitment of Janus Kinases and STAT5 Activation J. Biol. Chem., July 11, 2008; 283(28): 19465 - 19477. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Hamada, A. Sato, T. Hirano, T. Yamamoto, G. Son, M. Onodera, I. Torii, T. Nishigami, M. Tanaka, A. Miyajima, et al. Oncostatin M Gene Therapy Attenuates Liver Damage Induced by Dimethylnitrosamine in Rats Am. J. Pathol., September 1, 2007; 171(3): 872 - 881. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. D. Shingleton, D. Jones, X. Xu, T. E. Cawston, and A. D. Rowan Retinoic acid and oncostatin M combine to promote cartilage degradation via matrix metalloproteinase-13 expression in bovine but not human chondrocytes Rheumatology, August 1, 2006; 45(8): 958 - 965. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Cohen, S. Marchand-Adam, V. Lecon-Malas, J. Marchal-Somme, A. Boutten, G. Durand, B. Crestani, and M. Dehoux HGF synthesis in human lung fibroblasts is regulated by oncostatin M Am J Physiol Lung Cell Mol Physiol, June 1, 2006; 290(6): L1097 - L1103. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J Kimber Leukaemia inhibitory factor in implantation and uterine biology Reproduction, August 1, 2005; 130(2): 131 - 145. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Tanaka, Y. Hirabayashi, T. Sekiguchi, T. Inoue, M. Katsuki, and A. Miyajima Targeted disruption of oncostatin M receptor results in altered hematopoiesis Blood, November 1, 2003; 102(9): 3154 - 3162. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Nagata, H. Kai, R. Shibata, M. Koga, A. Yoshimura, and T. Imaizumi Oncostatin M, an Interleukin-6 Family Cytokine, Upregulates Matrix Metalloproteinase-9 Through the Mitogen-Activated Protein Kinase Kinase-Extracellular Signal-Regulated Kinase Pathway in Cultured Smooth Muscle Cells Arterioscler Thromb Vasc Biol, April 1, 2003; 23(4): 588 - 593. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. K. de Hooge, F. A. J. van de Loo, M. B. Bennink, D. S. de Jong, O. J. Arntz, E. Lubberts, C. D. Richards, and W. B. van den Berg Adenoviral Transfer of Murine Oncostatin M Elicits Periosteal Bone Apposition in Knee Joints of Mice, Despite Synovial Inflammation and Up-Regulated Expression of Interleukin-6 and Receptor Activator of Nuclear Factor-{kappa}B Ligand Am. J. Pathol., May 1, 2002; 160(5): 1733 - 1743. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ihn, K. Yamane, Y. Asano, M. Kubo, and K. Tamaki IL-4 Up-Regulates the Expression of Tissue Inhibitor of Metalloproteinase-2 in Dermal Fibroblasts Via the p38 Mitogen-Activated Protein Kinase-Dependent Pathway J. Immunol., February 15, 2002; 168(4): 1895 - 1902. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A F Wahl and P M Wallace Oncostatin M in the anti-inflammatory response Ann Rheum Dis, November 1, 2001; 60(90003): iii75 - 80. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Q. Li, F. Dehnade, and M. Zafarullah Oncostatin M-Induced Matrix Metalloproteinase and Tissue Inhibitor of Metalloproteinase-3 Genes Expression in Chondrocytes Requires Janus Kinase/STAT Signaling Pathway J. Immunol., March 1, 2001; 166(5): 3491 - 3498. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Langdon, C. Kerr, M. Hassen, T. Hara, A. L. Arsenault, and C. D. Richards Murine Oncostatin M Stimulates Mouse Synovial Fibroblasts in Vitro and Induces Inflammation and Destruction in Mouse Joints in Vivo Am. J. Pathol., October 1, 2000; 157(4): 1187 - 1196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ihn and K. Tamaki Oncostatin M Stimulates the Growth of Dermal Fibroblasts Via a Mitogen-Activated Protein Kinase-Dependent Pathway J. Immunol., August 15, 2000; 165(4): 2149 - 2155. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R B Heuschkel, T T MacDonald, G Monteleone, M Bajaj-Elliott, J A W. Smith, and S L F Pender Imbalance of stromelysin-1 and TIMP-1 in the mucosal lesions of children with inflammatory bowel disease Gut, July 1, 2000; 47(1): 57 - 62. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Solis-Herruzo, R. A. Rippe, L. W. Schrum, P. de la Torre, I. Garcia, J. J. Jeffrey, T. Munoz-Yague, and D. A. Brenner Interleukin-6 Increases Rat Metalloproteinase-13 Gene Expression through Stimulation of Activator Protein 1 Transcription Factor in Cultured Fibroblasts J. Biol. Chem., October 22, 1999; 274(43): 30919 - 30926. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Wallace, J. F. MacMaster, K. A. Rouleau, T. J. Brown, J. K. Loy, K. L. Donaldson, and A. F. Wahl Regulation of Inflammatory Responses by Oncostatin M J. Immunol., May 1, 1999; 162(9): 5547 - 5555. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Meisser, D. Chardonnens, A. Campana, and P. Bischof Effects of tumour necrosis factor-{alpha}, interleukin-1 {alpha}, macrophage colony stimulating factor and transforming growth factor ß on trophoblastic matrix metalloproteinases Mol. Hum. Reprod., March 1, 1999; 5(3): 252 - 260. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Loy, T. J. Davidson, K. K. Berry, J. F. Macmaster, B. Danle, and S. K. Durham Oncostatin M: Development of a Pleiotropic Cytokine Toxicol Pathol, March 1, 1999; 27(2): 151 - 155. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Varghese, K. Yu, and E. Canalis Leukemia inhibitory factor and oncostatin M stimulate collagenase-3 expression in osteoblasts Am J Physiol Endocrinol Metab, March 1, 1999; 276(3): E465 - E471. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tanaka, T. Hara, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, and A. Miyajima Reconstitution of the Functional Mouse Oncostatin M (OSM) Receptor: Molecular Cloning of the Mouse OSM Receptor beta Subunit Blood, February 1, 1999; 93(3): 804 - 815. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Q. Liand and M. Zafarullah Oncostatin M Up-Regulates Tissue Inhibitor of Metalloproteinases-3 Gene Expression in Articular Chondrocytes via De Novo Transcription, Protein Synthesis, and Tyrosine Kinase- and Mitogen-Activated Protein Kinase-Dependent Mechanisms J. Immunol., November 1, 1998; 161(9): 5000 - 5007. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. M. Botelho, D. R. Edwards, and C. D. Richards Oncostatin M Stimulates c-Fos to Bind a Transcriptionally Responsive AP-1 Element within the Tissue Inhibitor of Metalloproteinase-1 Promoter J. Biol. Chem., February 27, 1998; 273(9): 5211 - 5218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ihn, E. C. LeRoy, and M. Trojanowska Oncostatin M Stimulates Transcription of the Human alpha 2(I) Collagen Gene via the Sp1/Sp3-binding Site J. Biol. Chem., September 26, 1997; 272(39): 24666 - 24672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. F. Singer, E. Marbaix, I. Kokorine, P. Lemoine, J. Donnez, Y. Eeckhout, and P. J. Courtoy Paracrine stimulation of interstitial collagenase (MMP-1) in the human endometrium by interleukin 1alpha and its dual block by ovarian steroids PNAS, September 16, 1997; 94(19): 10341 - 10345. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ichihara, T. Hara, H. Kim, T. Murate, and A. Miyajima Oncostatin M and Leukemia Inhibitory Factor Do Not Use the Same Functional Receptor in Mice Blood, July 1, 1997; 90(1): 165 - 173. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Korzus, H. Nagase, R. Rydell, and J. Travis The Mitogen-activated Protein Kinase and JAK-STAT Signaling Pathways Are Required for an Oncostatin M-responsive Element-mediated Activation of Matrix Metalloproteinase 1Gene Expression J. Biol. Chem., January 10, 1997; 272(2): 1188 - 1196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L Blavier and J. Delaisse Matrix metalloproteinases are obligatory for the migration of preosteoclasts to the developing marrow cavity of primitive long bones J. Cell Sci., January 12, 1995; 108(12): 3649 - 3659. [Abstract] [PDF]
|
|
|
|
|
|
G. Dean, D. A. Young, D. R. Edwards, and I. M. Clark The Human Tissue Inhibitor of Metalloproteinases (TIMP)-1 Gene Contains Repressive Elements within the Promoter and Intron 1 J. Biol. Chem., October 13, 2000; 275(42): 32664 - 32671. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. M. Hermanns, S. Radtke, F. Schaper, P. C. Heinrich, and I. Behrmann Non-redundant Signal Transduction of Interleukin-6-type Cytokines. THE ADAPTER PROTEIN Shc IS SPECIFICALLY RECRUITED TO THE ONCOSTATIN M RECEPTOR J. Biol. Chem., December 22, 2000; 275(52): 40742 - 40748. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
